The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody.
about
Acquired immunity to malariaApplications of (19)F-NMR in Fragment-Based Drug DiscoveryProtein kinase a dependent phosphorylation of apical membrane antigen 1 plays an important role in erythrocyte invasion by the malaria parasiteFunctional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion processStructure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory AntibodyHost cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptideBabesia divergensandNeospora caninumapical membrane antigen 1 structures reveal selectivity and plasticity in apicomplexan parasite host cell invasionThe structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine designBiochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41Molecular insights into the interaction between Plasmodium falciparum apical membrane antigen 1 and an invasion-inhibitory peptideThe RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasitesA phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720Generation of humoral immune responses to multi-allele PfAMA1 vaccines; effect of adjuvant and number of component alleles on the breadth of responseBinding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion.Mimotopes of apical membrane antigen 1: Structures of phage-derived peptides recognized by the inhibitory monoclonal antibody 4G2dc1 and design of a more active analogueAn inhibitory antibody blocks interactions between components of the malarial invasion machinery.Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRon2 Does Not Improve the In Vitro Efficacy.Determination of the molecular basis for a limited dimorphism, N417K, in the Plasmodium vivax Duffy-binding protein.Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assaysStrategies for designing and monitoring malaria vaccines targeting diverse antigensIsolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 proteinTranscriptome sequencing and analysis of Plasmodium gallinaceum reveals polymorphisms and selection on the apical membrane antigen-1.Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in KenyaDefining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1.Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseGlobal Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1).Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.Expression, Purification, and Biological Characterization of Babesia microti Apical Membrane Antigen 1.Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies.Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.Structural basis of antigenic escape of a malaria vaccine candidateVaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum EpitopesSequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populations.Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implicationsPopulation structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design.Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru
P2860
Q24651173-526B0170-754A-44E5-BBE8-5C59A95838C1Q26738755-4E29656C-47C4-49FB-9F40-6EF629CABB68Q27314651-A81726DE-C6FF-4F16-9383-EB07BD468747Q27317456-59569F3A-596E-446D-B502-D708610F0D68Q27648686-3BE38B8C-BEEC-40D2-96AC-DDB19B4AC790Q27670931-CCCCE235-1D7C-4414-9281-51354BF343A0Q27675189-F7F11F9C-6BEA-4990-8324-C7621DD822D0Q27681234-7E63FE46-5C2B-431F-B25D-41C828F695C1Q28481599-0D56308C-5453-4632-8293-43B30A14055AQ28544106-C3549E92-EBE3-4F33-A614-3222AC0610A7Q28742887-124D3673-5E55-4D75-B924-3B7A89F29A12Q28744696-259D5BA1-C1A8-418E-940E-889BF46598E0Q28748610-F2B05AC5-A5F3-438E-873F-65C1E3F3A145Q30503482-2FEAD1E9-F7BD-465C-A40C-1CA3AD21FD51Q33261308-A2EE913A-8781-4E39-9FCF-50DF82ED2425Q33402457-FAFB54AD-3718-44A4-9886-E748DEBF52CEQ33835382-B8F55BA5-9477-4732-830F-504DD6914434Q33918156-8F194CF8-B3ED-4809-BE52-F7F03D06C286Q33925720-EDF72C42-FA87-41CD-8E7E-5CCCC38F7907Q33939788-C52E93A9-5A25-4804-B5A3-8607D3AA05B4Q33959038-4C387B00-71C5-480F-A216-BAB7DC30FD56Q34069682-4D192FC0-88EB-40D6-BC45-DE25773FC285Q34128586-C893C02A-9F0A-40CD-908C-92F0BC3BC182Q34278814-0F862983-2676-4BF0-8986-E9EAF8FDA47CQ34290806-481420E3-2F5B-471E-8657-F78B3A60CEAAQ34507190-9832307D-576B-44CE-A215-544EAFF2B645Q34596157-ECB13A8A-FE73-4814-9D3E-A22A381159E4Q34827195-D9FD0582-E1B7-4988-84E3-2C67C6A8BC2FQ34955461-ED696C77-E096-463C-B300-D78710F93ED1Q35037036-5CE959DC-EEAF-49DE-9132-78D32F01187FQ35079832-1EC2B010-141A-4462-89E6-31CA4B89E8DDQ35701584-719AA2D3-F95E-4BED-B08D-40752F49309CQ35805433-CA6EE42A-3FF8-47EB-8B3A-F427B3DEB674Q35862464-A2173433-1DCD-498E-8461-D1576D12ED07Q35927982-57D39AE5-5CC7-4B3B-B058-2DCE57022259Q36151198-36F47205-33C9-49FB-80DA-9DEE7935C87CQ36398138-687C7062-76BF-414D-A1CB-128FA6860765Q36509831-9E323B93-56E1-457E-ADA6-89E673237ECFQ36693957-03EB5A34-E501-4F6C-BF90-9442190A68EFQ36728804-E302B743-203C-48B7-97EF-7645F5450BAF
P2860
The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The most polymorphic residue o ...... invasion-inhibitory antibody.
@ast
The most polymorphic residue o ...... invasion-inhibitory antibody.
@en
The most polymorphic residue o ...... invasion-inhibitory antibody.
@nl
type
label
The most polymorphic residue o ...... invasion-inhibitory antibody.
@ast
The most polymorphic residue o ...... invasion-inhibitory antibody.
@en
The most polymorphic residue o ...... invasion-inhibitory antibody.
@nl
prefLabel
The most polymorphic residue o ...... invasion-inhibitory antibody.
@ast
The most polymorphic residue o ...... invasion-inhibitory antibody.
@en
The most polymorphic residue o ...... invasion-inhibitory antibody.
@nl
P2093
P2860
P1476
The most polymorphic residue o ...... invasion-inhibitory antibody.
@en
P2093
A H Batchelor
K S Harris
R F Anders
R Masciantonio
V J Murphy
P2860
P304
P356
10.1128/IAI.74.5.2628-2636.2006
P407
P577
2006-05-01T00:00:00Z